Patients with RA receive less protection from pandemic influenza with H1N1 vaccine

Individuals with rheumatoid arthritis taking disease modifying anti-rheumatic drugs, showed significantly less protection from pandemic influenza after receiving the H1N1 vaccine compared to healthy individuals, according to data presented today at the EULAR 2011 Annual Congress.

A Brazilian hospital-based study assessed responses to flu vaccines in 340 RA patients in regular follow-up compared to 234 healthy patients. Measures of protection obtained by vaccination (seroprotection rate (SP)) after immunization was over 20% lower for RA patients compared to healthy individuals (60.1% vs. 82.9% comparatively (p<0.001)). tests to determine levels of detectable antibodies to microorganisms in the blood serum as a result of infection and immunization with the flu virus (seroconversion rate (sc)) showed a similar pattern with 53.4% of ra patients and 76.9% of healthy controls having antibodies present respectively (p<0.001).

"This study has highlighted that there are differences in the level of protection between the H1N1 vaccine and the seasonal influenza so healthcare professionals should not assume that response will be the same with different vaccines" said Professor A. Ribeiro of the University of Sao Paolo. "In planning for future pandemic outbreaks, healthcare professionals should consider specific immunization strategies to ensure this large population of patients are as fully protected as possible from the risk of contracting pandemic flu."

The vaccination's impact on disease activity (DAS28*) was also measured and nine patients (2.6%) reported worsening of symptoms with the mean disease activity score changing from 3.66 to 5.15 (p<0.05) after the h1n1 vaccination. no were seen across either patient group, although more subjects in the ra patient group reported more adverse events, 42% versus 30.8% with a rate of 140 events/100 patients versus 87/100 control group (p<0.005).

More information: * DAS28 (Disease Activity Score) is an index used by physicians to measure how active an individual's RA is. It assesses number of tender and swollen joints (out of a total of 28), the ethroycyte sedimentation rate (ESR, a blood marker of inflammation), and the patient's 'global assessment of global health'. A higher score indicates more active disease.

Related Stories

Rheumatoid arthritis: Worse in women?

date Jan 14, 2009

Women appear to suffer more from rheumatoid arthritis (RA) than men. This is revealed in research published in BioMed Central's open access journal Arthritis Research and Therapy.

Country economy is a stronger predictor of therapy initiation

date Jun 18, 2010

There is significant disparity between 'richer' and 'poorer' countries in terms of access to biological treatments for rheumatoid arthritis (RA), according to results from a multinational study across four continents presented ...

Recommended for you

Aspirin to improve leg ulcers

date 13 hours ago

Researchers are looking at whether aspirin can improve the healing rates of leg ulcers in older adults.

Sierra Leone marks grim Ebola anniversary

date 17 hours ago

On May 24 last year a pregnant woman and an older housewife staggered into Kenema hospital in eastern Sierra Leone and were diagnosed within a day as the country's first Ebola cases.

MSF fighting cholera outbreak in Tanzania refugee camps

date May 24, 2015

Medical charity Medecins sans Frontieres (MSF, Doctors Without Borders) said Sunday it had launched emergency treatment centres in Tanzania, where thousands of Burundians fleeing unrest have been hit by cholera.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.